Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Wen, Patrick
Item TypeName
Academic Article Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.
Academic Article Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide.
Academic Article Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Academic Article Results of linear accelerator-based radiosurgery for intracranial meningiomas.
Academic Article A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas.
Academic Article A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas.
Academic Article A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.
Academic Article A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.
Academic Article Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.
Academic Article CNS Hodgkin lymphoma.
Academic Article Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.
Academic Article Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
Academic Article A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
Academic Article A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
Academic Article Management of brain metastases.
Academic Article Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
Academic Article An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma.
Academic Article Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
Academic Article Therapy for recurrent high-grade gliomas: does continuous dose-intense temozolomide have a role?
Academic Article Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.
Academic Article Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion.
Academic Article Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs.
Academic Article Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas.
Academic Article Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Academic Article A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.
Academic Article Treatment of recurrent high-grade gliomas.
Academic Article Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study.
Academic Article Recurrent acute promyelocytic leukemia presenting as a sacral nerve root mass.
Academic Article Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.
Academic Article A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.
Academic Article Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study.
Academic Article Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Academic Article Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.
Academic Article The treatment of recurrent brain metastases with stereotactic radiosurgery.
Academic Article Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.
Academic Article Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?
Academic Article Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas.
Academic Article Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
Academic Article A phase II trial of oral gimatecan for recurrent glioblastoma.
Academic Article Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.
Academic Article Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects.
Academic Article Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Academic Article Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
Academic Article A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03.
Academic Article Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept.
Academic Article Therapy for recurrent malignant glioma in adults.
Academic Article Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.
Academic Article Phase II study of GleevecĀ® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.
Academic Article AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Academic Article Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas.
Academic Article Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma.
Academic Article Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma.
Academic Article Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
Academic Article Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study.
Academic Article Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.
Academic Article Polysomy for chromosomes 1 and 19 predicts earlier recurrence in anaplastic oligodendrogliomas with concurrent 1p/19q loss.
Academic Article Phase I trial of tipifarnib in patients with recurrent malignant glioma taking enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.
Academic Article Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab.
Academic Article Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma.
Academic Article Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.
Academic Article Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme.
Academic Article Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
Academic Article Interferon therapy for recurrent gliomas.
Academic Article Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Concept Neoplasm Recurrence, Local
Concept Recurrence
Academic Article Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.
Academic Article Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
Academic Article Enhancing radiation therapy for patients with glioblastoma.
Academic Article Phase I study of GRN1005 in recurrent malignant glioma.
Academic Article Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival.
Academic Article Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma.
Academic Article Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
Academic Article Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.
Academic Article Bevacizumab for glioblastoma: what can we learn from patterns of progression?
Academic Article Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab.
Academic Article Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
Academic Article Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Academic Article Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study.
Academic Article Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.
Academic Article Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.
Academic Article A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
Academic Article Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Academic Article The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab.
Academic Article Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
Academic Article Author response.
Academic Article Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model.
Academic Article Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
Academic Article Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma.
Academic Article Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma.
Academic Article A phase II study of XL184 in patients (pts) with progressive glioblastoma multiforme (GBM) in first or second relapse.
Academic Article Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.
Academic Article Angiogenesis inhibitors in tackling recurrent glioblastoma.
Academic Article Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab.
Academic Article Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials.
Academic Article Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Academic Article Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
Academic Article Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.
Academic Article Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
Academic Article Diagnostic accuracy of 2-hydroxyglutarate magnetic resonance spectroscopy in newly diagnosed brain mass and suspected recurrent gliomas.
Academic Article Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
Academic Article Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma.
Academic Article PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma.
Academic Article Voxel-Wise Analysis of Fluoroethyltyrosine PET and MRI in the Assessment of Recurrent Glioblastoma During Antiangiogenic Therapy.
Academic Article Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.
Academic Article Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Academic Article A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma.
Search Criteria
  • Recurrence
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.